Michael R. Hayden serves as Executive at Xenon Pharmaceuticals Inc., where they oversee executive responsibilities. Since joining the company, Michael R. Hayden has executed 56 insider transactions totaling $5.7M, demonstrating a bullish approach to their equity position. Their most recent transaction on May 25, 2016 involved exercising options for 8,230 shares valued at $27.2K.
Michael R. Hayden currently holds 54,298 shares of Xenon Pharmaceuticals Inc. (XENE), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Michael R. Hayden has been a net buyer of XENE stock. They have purchased $3.2M and sold $2.5M worth of shares.
Michael R. Hayden's most recent insider trade was on May 25, 2016, when they sold 8,230 shares at $3.30 per share.
Get notified when new Form 4 filings are submitted
| 5,144 |
| $4.81 |
| Discretionary |
| Jan 8, 2015 | XENE | $25.6K | Option Exercise | 5,144 | $4.98 | Discretionary |
| Nov 9, 2014 | XENE | $0 | Conversion | 2,693 | $N/A | Discretionary |
| Nov 9, 2014 | XENE | $0 | Conversion | 10,030 | $N/A | Discretionary |
| Nov 9, 2014 | XENE | $0 | Conversion | 1,504 | $N/A | Discretionary |